NADMED forms global Scientific Advisory Board to advance redox diagnostics and precision medicine
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
Former Novo Nordisk and Pharmanovia executive to lead next growth phase in NAD diagnostics and personalised health innovation
Subscribe To Our Newsletter & Stay Updated